Results 1 to 10 of about 38,949 (262)
Interim opioid agonist treatment for opioid addiction: a systematic review [PDF]
Harm Reduction Journal, 2022 Background Opioid use disorder is a public health problem and treatment variability, coverage and accessibility poses some challenges. The study’s objective is to review the impact of interim opioid agonist treatment (OAT), a short-term approach for ...
Laura Samsó Jofra +3 more
doaj +6 more sources
Journal of Substance Abuse Treatment, 2020 Patients recovering from opioid use disorders (OUD) may be prone to relapse and opioid misuse in the postoperative period due to re-exposure to prescription opioids for pain control. This retrospective study analyzed the incidence of confirmed opioid misuse in the postoperative period in patients with OUDs enrolled in an opioid agonist treatment (OAT ...
Khodadad Namiranian
exaly +4 more sources
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
Addiction Science & Clinical Practice, 2022 Background Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction requirements, employment ...
Nathaniel Day, Maureen Wass, Kelly Smith
doaj +3 more sources
European Psychiatry, 2023 Introduction Studies consistently show that patients with prescription opioid use disorder (OUD) respond to buprenorphine treatment. Few studies have followed these patients in the long-term.
R. Weiss, M. L. Griffin
doaj +1 more source
Opioid Substitution: More than Only Methadone!
European Psychiatry, 2022 Opioid misuse and its rising rates of morbidity and associated mortality is an increasing area of concern worldwide. The licit/illicit consumption of opioids ranging from plant-based substances and pharmaceutical drugs (particularly analgesia) to the new
M. Torrens
doaj +1 more source
Alcohol use in opioid agonist treatment [PDF]
Addiction Science & Clinical Practice, 2016 Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid use disorder individually, less is known about how best ...
Nolan, Seonaid, Klimas, Jan, Wood, Evan
openaire +4 more sources
Substance Abuse Treatment, Prevention, and Policy, 2022 Background Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), who face an elevated risk of ...
Heather Palis +6 more
doaj +1 more source
BMJ Open, 2021 Objective To describe opioid agonist treatment prescribing rates in provincial prisons and compare with community prescribing rates.Design We used quarterly, cross-sectional data on the number and proportion of people prescribed opioid agonist treatment ...
Fiona Kouyoumdjian +4 more
doaj +1 more source
Harm Reduction Journal, 2021 Background For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine ...
Heather Palis +3 more
doaj +1 more source
International Journal of Population Data Science, 2022 Objectives There are critical periods of mortality risk at onset and cessation of opioid agonist treatment. We aim to determine whether non-fatal overdose followed the same pattern as fatal overdose, comparing the first 4 weeks of treatment and ...
Nicola Jones +6 more
doaj +1 more source